Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +12

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Evaluation Expert Panel on Detection · JAMA · 2001 · 26K citations

Medicine, Cardiology, Otolaryngology +10

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

The Lancet · 2002 · 7K citations

Medicine, Cardiology, Pharmacotherapy +13

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

Göran Walldius, Ingmar Jungner, Ingar Holme et al. · The Lancet · 2001 · 1.2K citations

Medicine, Cardiology, Internal Medicine +17

Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions

A. Richey Sharrett, Christie M. Ballantyne, Sean A. Coady et al. · Circulation · 2001 · 939 citations · Full text

Medicine, Cardiology, Preventive Medicine +17